Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 1998 January-February;64(1-2) > Minerva Anestesiologica 1998 January-February;64(1-2):35-43





A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care

Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036




Minerva Anestesiologica 1998 January-February;64(1-2):35-43

language: Italian

Therapy of articular and periarticular pain of the knee with local anesthetics (neuraltherapy by Huneke). Short and long term results

Barbagli P., Bollettin R.

Ambulatorio di Terapia Antalgica, Riva del Garda (Trento)


Objective. Assessment of the outcomes on the articular and periarticular pain of the knee, by a reflexotherapy with local anesthetics, denominated also neuraltherapy.
Experimental disegn. Retrospective observational study with 3 years’ follow-up.
Environment. An Ambulatory Center for Pain Management.
Patients. All the patients (N=115) with knee pain treated with neuraltherapy in the period 1982-31 August 1996 (retired patients 2, mean age 68±15.2 years in the remaining).
Interventions. The employed reflexotherapy, denominated also neuraltherapy by Huneke, uses a local anesthetic (prevalently lidocaine) in 0.5-1% concentration and small quantity (0,5-1 ml for point) on tender/trigger and/or acupuncture points, as well as in anatomical structures like articulations, nerves, arteries or veins. The number of sessions has been of 7.03±3.3.
Outcome measures. Outcomes are evaluated in terms of percentage subjective improvement of the pain at the end of the therapy and at 1-3-6 months, 1-2-3 years, and then divided in 5 groups (no improvement - fair - good - very good- excellent).
Results. At the end of the therapy the improven cases were the 91.2%, the 83.7% at 1 month, the 64.6% at 3 months, the 41.3% at 6 months, the 22.5% at 1 year, the 12.1% at 2 years and the 7.9% at 3 years.
Conclusions. These outcomes suggest a good effectiveness of this treatment in the painful diseases of the knee, but further randomised double-blind trials are necessary.

top of page

Publication History

Cite this article as

Corresponding author e-mail